HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $61,813 | -21.5% | 14,375 | +0.2% | 0.01% | -22.2% |
Q2 2023 | $78,727 | +30.7% | 14,340 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $60,228 | +51.6% | 14,340 | 0.0% | 0.01% | +50.0% |
Q4 2022 | $39,722 | +7.4% | 14,340 | 0.0% | 0.01% | -33.3% |
Q3 2022 | $37,000 | -73.8% | 14,340 | -63.5% | 0.01% | -75.7% |
Q2 2022 | $141,000 | -40.8% | 39,300 | +2.6% | 0.04% | -27.5% |
Q1 2022 | $238,000 | -11.9% | 38,300 | 0.0% | 0.05% | -12.1% |
Q4 2021 | $270,000 | +1.1% | 38,300 | 0.0% | 0.06% | +9.4% |
Q3 2021 | $267,000 | -16.3% | 38,300 | 0.0% | 0.05% | -28.4% |
Q2 2021 | $319,000 | – | 38,300 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |